RDVI ETF Analysis: FT Cboe Vest Rising | BATS

Derivative Income | BATS, USA | Market Cap: 3.676m USD | 12M Return: 20.7% | US33738D8790 | Charts, Fundamentals & Technical Analysis

Dividend Stocks, Covered Calls, Equity Options, Income Derivatives
Total Rating 58
Safety 71
Buy Signal -0.04
Derivative Income
Category Rotation: +9.6
TER: 0.75%
AUM: 3.68B
Avg Turnover: 33.5M
Risk 3d forecast
Volatility14.1%
VaR 5th Pctl2.50%
VaR vs Median-1.42%
Reward TTM
Sharpe Ratio1.11
Rel. Str. IBD57.2
Rel. Str. Peer Group47.3
Character TTM
Beta0.818
Beta Downside0.789
Hurst Exponent0.461
Drawdowns 3y
Max DD18.35%
CAGR/Max DD1.12
CAGR/Mean DD8.63

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 3.9 years of data

Jan +1.9% 38
Feb -1.7% 15
Mar -4.0% 15
Apr -2.7% 14
May +0.4% 11
Jun +3.8% 16
Jul +0.2% 11
Aug -1.1% 14
Sep -0.1% 0
Oct -1.5% 38
Nov +6.6% 39
Dec +0.0% 11

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RDVI FT Cboe Vest Rising

RDVI is a derivative income ETF that invests at least 80% of its net assets in dividend-paying securities, with the adviser seeking to enhance distributions by combining stock dividends with premiums from options strategies (typically a covered call overlay) on the underlying holdings.

The fund targets an annual distribution rate of approximately 8.0% above the current dividend yield of the S&P 500 Index. It is classified as a non-diversified fund, launched in October 2022, and is structured as a U.S.-listed mid-cap ETF on the Cboe BATS exchange, focusing on rising dividend achievers within the equity income space.

Headlines to Watch Out For
  • Option premium income declines as market volatility falls
  • Rising interest rates pressure dividend stock valuations relative to bonds
  • Competition intensifies from JEPI and JEPQ covered call ETFs
What is the price of RDVI shares?

As of September 27, 2026, the stock is trading at USD 28.18 with a total of 1,608,678 shares traded. Over the past week, the price has changed by +0.15%, over one month by -3.27%, over three months by -0.63% and over the past year by +20.65%.

Current recommended Stop Loss: 27.80 (which is 1.3% or 1.3 ATR below the current price).

Is RDVI a buy, sell or hold?

FT Cboe Vest Rising has no consensus analysts rating.